Skip to main content
Log in

KLF6mRNA expression in primary hepatocellular carcinoma

  • Published:
Current Medical Science Aims and scope Submit manuscript

Summary

To investigate the expression of KLF6mRNA in primary hepatocellular carcinoma (HCC), nomal liver tissues and the tissues adjacent to the cancers, reverse-transcription polymerase chain reaction (RT-PCR) was employed to investigate the expression of the KLF6 gene in HCC, the corresponding adjacent non-cancerous tissues and normal liver tissue. Our results showed that an amplified fragment of 127 bp DNA was detected in 18 of 19 (94.7%) adjacent non-cancerous tissues and normal liver tissue, and in 12 (85.7%) of 11 HCC. There were no significant differences in the levels of KLF6 mRNA between normal liver and liver tumors (P>0.05). It is concluded that KLF6 mRNA is generally expressed in HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zhang X, Xu H J, Murakami Yet al. Deletions of chromosome 13q, mutations in retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res, 1994, 54: 1177

    Google Scholar 

  2. Lin Y W, Sheu J C, Liu L Yet al. Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions. Eur J Cancer, 1999, 35: 1730

    Article  CAS  PubMed  Google Scholar 

  3. Ng I O, Srivastava G, Chung L Pet al. Overexpression and point mutations of p53 tumor suppressor gene in hepatocellular carcinomas in Hong Kong Chinese people. Cancer, 1991, 71: 30

    Google Scholar 

  4. Vautier G, Bomford A B, Portmann B Cet al. p53 mutations in British patients with hepatocellular carcinoma: clustering in genetic hemochromatosis. Gatroenterology, 1999, 117: 151

    Article  Google Scholar 

  5. Gerbes A L, Caselmann W H. Point mutations of the P53 gene, human hepatocellular carcinoma and aflatoxins. J Hepatol, 1993, 19: 312

    Article  CAS  PubMed  Google Scholar 

  6. Rashid A, Wang J S, Qian G Set al. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 1q and p53 gene mutation. Br J Cancer, 1999, 80: 59

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Yumoto Y, Hanafusa T, Hada Het al. Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma. J Gastroenterol Hepatol, 1995, 10: 179

    Article  CAS  PubMed  Google Scholar 

  8. Leon M, Kew M C. Analysis of ras gene mutations in hepatocellular carcinoma in southern African blacks. Anticancer Res, 1995, 15: 859

    CAS  PubMed  Google Scholar 

  9. Stork P, Loda M, Bosari Set al. Detection of K-ras mutation in pancreatic neoplasm by nonisotopic mismatched polymerase chain reaction. Oncogene, 1991, 6: 857

    CAS  PubMed  Google Scholar 

  10. Ratziu V, Lalazar A, Wong Let al. Zf9, A Kruppel-like transcription factor up-regulatedin vivo during early hepatic fibrosis. Proc Natl Acad Sci USA. 1998, 95: 9500

    Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

  11. Koritschoner N P, Bocco J L, Panzetta-Dutari G Met al. A Novel Human Zinc Finger Protein That Interacts with the Core Promoter Element of a TATA Box-less gene. J Biol Chem. 1997, 272: 9573

    Article  CAS  PubMed  Google Scholar 

  12. Suzuki T, Yamamoto T, Kurabayashi Met al. Isolation and initial characterization of GBF, a novel DNA-binding zinc finger protein that binds to the GC-rich binding sites of the HIV-1 promoter. J Biochem, 1998, 121: 389

    Article  Google Scholar 

  13. Bieker J J. Kruppel-like Factors: Three Fingers in Many Pies. J Biol Chem, 2001, 276: 34355

    Article  CAS  PubMed  Google Scholar 

  14. Kim Y, Ratziu V, Choi S Get al. Transcriptional activation of transforming growth factor betal and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. J Biol Chem, 1998, 273: 33750

    Article  CAS  PubMed  Google Scholar 

  15. Kojima S, Hayashi S, Shimokado Ket al. Transcriptional activation of urokinase by the Krüppel-like factor Zf9/COPEB activates latent TGF- 1 in vascular endothelial cells. Blood, 2000, 95: 1309

    CAS  PubMed  Google Scholar 

  16. Narla G, Heath K E, Reeves H Let al. KLF6, A Candidate Tumor Suppressor Gene Mutated in Prostate Cancer. Science, 2001, 294: 2563

    Article  CAS  PubMed  ADS  Google Scholar 

  17. Narla G, Heath K E, Reeves H Let al. KLF6, a Candidate Tumor Suppressor Gene Mutated in Prostate Cancer Supplementary material is available on science online at www. sciencemag. org/cgi/content/full294/5551/2563/DC1

Download references

Author information

Authors and Affiliations

Authors

Additional information

Wang Shaoping made born in 1965. Associate Professor

This study was supported by the Clinical Key Discipline of Chinese Ministry of Public Health (No. 200 321).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shaoping, W., Xiaoping, C., Wanguang, Z. et al. KLF6mRNA expression in primary hepatocellular carcinoma. Current Medical Science 24, 585–587 (2004). https://doi.org/10.1007/BF02911362

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02911362

Key words

Navigation